A sequence of imaging AI studies reported new approaches to predict tumor features without invasive sampling, including a model that reads routine CT urography to predict bladder cancer HER2 status and another whole-lung radiomics system intended to forecast which lung cancer patients will achieve complete pathologic response to neoadjuvant immunotherapy.